Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency - PubMed (original) (raw)
Review
. 2004 Feb 26;350(9):913-22.
doi: 10.1056/NEJMra032207.
Affiliations
- PMID: 14985489
- DOI: 10.1056/NEJMra032207
Review
Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency
Matthew P McCormack et al. N Engl J Med. 2004.
No abstract available
Comment in
- LMO2 and gene therapy for severe combined immunodeficiency.
Fischer A, Abina SH, Thrasher A, von Kalle C, Cavazzana-Calvo M. Fischer A, et al. N Engl J Med. 2004 Jun 10;350(24):2526-7; author reply 2526-7. doi: 10.1056/NEJM200406103502422. N Engl J Med. 2004. PMID: 15190153 No abstract available. - LMO2 and gene therapy for severe combined immunodeficiency.
Stone BD. Stone BD. N Engl J Med. 2004 Jun 10;350(24):2526-7; author reply 2526-7. N Engl J Med. 2004. PMID: 15195349 No abstract available.
Similar articles
- LMO2 and gene therapy for severe combined immunodeficiency.
Fischer A, Abina SH, Thrasher A, von Kalle C, Cavazzana-Calvo M. Fischer A, et al. N Engl J Med. 2004 Jun 10;350(24):2526-7; author reply 2526-7. doi: 10.1056/NEJM200406103502422. N Engl J Med. 2004. PMID: 15190153 No abstract available. - Gene therapy insertional mutagenesis insights.
Davé UP, Jenkins NA, Copeland NG. Davé UP, et al. Science. 2004 Jan 16;303(5656):333. doi: 10.1126/science.1091667. Science. 2004. PMID: 14726584 No abstract available. - LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M. Hacein-Bey-Abina S, et al. Science. 2003 Oct 17;302(5644):415-9. doi: 10.1126/science.1088547. Science. 2003. PMID: 14564000 - Occurrence of leukaemia following gene therapy of X-linked SCID.
Kohn DB, Sadelain M, Glorioso JC. Kohn DB, et al. Nat Rev Cancer. 2003 Jul;3(7):477-88. doi: 10.1038/nrc1122. Nat Rev Cancer. 2003. PMID: 12835668 Review. - Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW, Dunbar CE, Sorrentino BP. Nienhuis AW, et al. Mol Ther. 2006 Jun;13(6):1031-49. doi: 10.1016/j.ymthe.2006.03.001. Epub 2006 Apr 19. Mol Ther. 2006. PMID: 16624621 Review.
Cited by
- Exploring the potential of nanomedicine for gene therapy across the physicochemical and cellular barriers.
Hameed H, Sarwar HS, Younas K, Zaman M, Jamshaid M, Irfan A, Khalid M, Sohail MF. Hameed H, et al. Funct Integr Genomics. 2024 Sep 28;24(5):177. doi: 10.1007/s10142-024-01459-z. Funct Integr Genomics. 2024. PMID: 39340586 Review. - Analysis and comparative evaluation of expedited programs for gene therapy products: insights from the United States, the European Union, Japan, and South Korea.
Jeong H, Purja S, Kim E. Jeong H, et al. Gene Ther. 2024 May;31(5-6):242-254. doi: 10.1038/s41434-023-00437-7. Epub 2024 Jan 10. Gene Ther. 2024. PMID: 38200263 - Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives.
Palmieri M, Pozzer D, Landsberger N. Palmieri M, et al. Front Neurosci. 2023 May 25;17:1172805. doi: 10.3389/fnins.2023.1172805. eCollection 2023. Front Neurosci. 2023. PMID: 37304036 Free PMC article. Review. - Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition.
Abdulla HD, Alserihi R, Flensburg C, Abeysekera W, Luo MX, Gray DHD, Liu X, Smyth GK, Alexander WS, Majewski IJ, McCormack MP. Abdulla HD, et al. J Exp Med. 2023 Jun 5;220(6):e20212383. doi: 10.1084/jem.20212383. Epub 2023 Mar 15. J Exp Med. 2023. PMID: 36920307 Free PMC article. - RAISING is a high-performance method for identifying random transgene integration sites.
Wada Y, Sato T, Hasegawa H, Matsudaira T, Nao N, Coler-Reilly ALG, Tasaka T, Yamauchi S, Okagawa T, Momose H, Tanio M, Kuramitsu M, Sasaki D, Matsumoto N, Yagishita N, Yamauchi J, Araya N, Tanabe K, Yamagishi M, Nakashima M, Nakahata S, Iha H, Ogata M, Muramatsu M, Imaizumi Y, Uchimaru K, Miyazaki Y, Konnai S, Yanagihara K, Morishita K, Watanabe T, Yamano Y, Saito M. Wada Y, et al. Commun Biol. 2022 Jun 2;5(1):535. doi: 10.1038/s42003-022-03467-w. Commun Biol. 2022. PMID: 35654946 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical